Pediatrix Medical (MD) EV to CFO (2009 - 2026)

Pediatrix Medical (MD) has reported EV to CFO for 18 consecutive years, with 13.19 the latest figure, recorded in Q2 2026.

• On a quarterly basis, EV to CFO rose 104.89% year-over-year to 13.19 in Q2 2026; TTM through Jun 2026 was 6.66, a 91.02% increase from a year earlier, with the FY2025 full-year figure at 4.64, up 29.59% from the prior year.
• EV to CFO was 13.19 for Q2 2026 at Pediatrix Medical, up from 10.98 in the prior quarter.
• Over five years, EV to CFO peaked at 20.13 in Q2 2022 and troughed at 20.01 in Q1 2022.
• A 5-year average of 4.18 and a median of 7.37 in 2024 frame the typical range for EV to CFO.
• Across the five-year window, EV to CFO sank 60.61% in 2024 and surged 104.89% in 2026, its largest moves.
• Over 5 years, EV to CFO stood at 11.04 in 2022, then decreased by 25.12% to 8.27 in 2023, then plunged by 30.2% to 5.77 in 2024, then soared by 92.78% to 11.13 in 2025, then climbed by 18.56% to 13.19 in 2026.
• The last three EV to CFO figures came in at 13.19 (Q2 2026), 10.98 (Q1 2026), and 11.13 (Q4 2025), per Business Quant data.